MTM Financial Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
MTM Financial Group's BMY Position: Q3 2026 in Review
MTM Financial Group held its Bristol-Myers Squibb (BMY) position steady in Q3 2026 at 5,390 shares worth $336K. The position accounts for 0.14% of the portfolio, ranked #71.
MTM Financial Group first reported a position in BMY in Q1 2022 and has held it in 19 quarters since. The position peaked at $602K in Q2 2022. 2,560 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- MTM Financial Group held 5,390 shares of Bristol-Myers Squibb worth $336K as of Q3 2026.
- MTM Financial Group left its Bristol-Myers Squibb share count unchanged in Q3 2026.
- Bristol-Myers Squibb made up 0.14% of MTM Financial Group's portfolio in Q3 2026, its #71 holding.
- MTM Financial Group first reported a position in Bristol-Myers Squibb in Q1 2022 and has held it in 19 quarters since.
- MTM Financial Group's Bristol-Myers Squibb position peaked at $602K in Q2 2022.
- 2,560 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on MTM Financial Group's 13F filing for Q3 2026, filed 13 Nov 2026.